Navigation Links
Kidney Patients Risk Heart Attacks

A new study shows kidney patients have far more to be concerned about than only their kidneys. The American Heart Association-sponsored study shows //people with chronic kidney disease are in the highest risk group for heart disease. Doctors say the most surprising finding was that this also applies to people who are in the very early stages of kidney disease.

Doctors have known patients in end-stage renal disease have a greater risk of heart attacks. Researchers from Tufts-New England Medical Center in Boston say their concern is for the 20 million Americans who have early kidney disease. That group along with the number of people with advanced kidney disease is alarming. The number of people with kidney failure treated by dialysis is expected to surpass 650,000 by the year 2010.

From these findings, the researchers urge all doctors to be aware that kidney patients fall into the highest risk category for cardiovascular disease. The American Heart Association also recommends physicians periodically test the kidney function of people with certain conditions including high blood pressure, diabetes and existing heart disease. From there, treatment can be started early. Mark Sarnak, M.D., co-author of the study, is quoted as saying, "There are some very good treatments for kidney disease, and fortunately, there isn’t a medication that is good for the kidney that is bad for the heart."

They also say more research is needed. Specifically, the study authors are calling for randomized controlled studies of treatments for heart disease in chronic kidney disease patients
'"/>




Page: 1

Related medicine news :

1. Is Diabetes the Leading Cause of Kidney Failure in India
2. Kidney Stones - Interesting New Research implicates bacteria as its cause
3. Moderate Use of Analgesics - Not Associated With Kidney Dysfunction
4. New Dietary Approach To Manage Kidney Stones
5. Kidney cancer on the rise
6. Kidney function can be affected by lead exposure
7. Kidney Failure after Non-Kidney Transplants
8. Kidney Patients Risk Heart Attacks
9. Urine Test for Kidney Cancer
10. New Hope for Kidney Failure
11. Hope for Patients With Kidney Failure
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/25/2017)... Fl (PRWEB) , ... April 25, 2017 , ... There ... Memorial Regional Hospital, according to a special report in the May issue of Consumer ... its highest quality ranking for results achieved during and after coronary bypass and ...
(Date:4/24/2017)... ... April 24, 2017 , ... LG CNS ... Own Device (BYOD) capabilities at Telehealth 2.0, the American Telemedicine Association’s national conference. ... pairs medical devices with a pre-programmed tablet in a remarkably easy-to-use kit for ...
(Date:4/24/2017)... (PRWEB) , ... April 24, 2017 , ... As part ... Museum today to honor the victims of the Holocaust and Nazi persecution, Center ... at Hadamar and Auschwitz on its CMATH Champions trip to Germany and Poland next ...
(Date:4/24/2017)... Calif. (PRWEB) , ... April 24, 2017 , ... The ... $1.6 million in charitable dental services to 1,961 people during the April 22-23 event ... at no charge to Californians who experience barriers to care, CDA Cares educates the ...
(Date:4/24/2017)... Boca Raton, Florida (PRWEB) , ... April 24, ... ... that develops a variety of unique liquid food supplements, announced its popular products ... of nutritional products. , ALP Nutrition® prioritizes the use of premium natural ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... --  ZappRx, Inc ., a digital health company focused on ... it closed $25 million in Series B funding led by ... Seattle that is part of a ... B round included participation from SR One , who ... (formerly Google Ventures). As part of the financing, ...
(Date:4/20/2017)... 20, 2017 Research and Markets has ... Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, ... their offering. ... pharmacogenomics market was valued at US$ 7,167.6 Mn in 2015, ... expanding at a CAGR of 5.6% from 2016 to 2024. ...
(Date:4/20/2017)... , April 20, 2017 NeuroVive Pharmaceutical ... today announced positive preclinical results demonstrating anti-fibrotic ... for non-alcoholic steatohepatitis (NASH), in an additional ... NV556 has previously shown similar anti-fibrotic ... Today, NeuroVive,s scientists present novel data demonstrating ...
Breaking Medicine Technology: